Literature DB >> 14758786

[Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues].

Bernard Bannwarth1, Fabienne Péhourcq.   

Abstract

The advantage of paracetamol (acetaminophen) is that it can be administered via the oral, intravenous or rectal routes. The last mentioned differs from the oral route in the slow and irregular absorption of the active substance. At therapeutic concentrations, the pharmacokinetics of paracetamol are linear--that is, independent of the dose, and constant with repeated administration. The efficacy of paracetamol has been demonstrated in a wide variety of acute or chronic painful syndromes. In adults, the optimum unit dose is 1 g. The maximum daily dosage is 4 g, consistent with the decline in analgesic activity, which is usually over 6 hours. With effervescent tablets, drug absorption and onset of action are more rapid than with conventional tablets. However, there is no direct correlation between serum concentrations of paracetamol and its analgesic or antipyretic effect. Paracetamol is the non-opiate analgesic of choice in elderly persons or patients with chronic renal insufficiency, and it is usually not necessary to reduce the dosage in such individuals, even though clearance is reduced. Although the bioavailability of paracetamol is not impaired in patients with chronic, benign liver diseases, the agent is contraindicated in those with hepatic insufficiency. It can be used during pregnancy and lactation. The very low level of paracetamol binding to plasma proteins, together with its hepatic metabolism, mainly through glucuronide or sulphate conjugation, account for the low risk of drug interactions with paracetamol, particularly with antivitamin K. When added to a traditional non-steroidal anti-inflammatory drug, paracetamol enhances the analgesic effect or allows the use of lower doses. It is more difficult to define the ideal dosage of paracetamol in children, because of the influence of age on its pharmacokinetics, and the relatively erratic bioavailability of suppositories. An oral dose of 15 mg/kg every 4 hours, up to a total of 60 mg/kg/day, is usually sufficient to achieve the desired analgesic or antipyretic effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14758786

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

Review 1.  Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain.

Authors:  Antonio Gatti; Elisabetta Sabato; Anna Rita Di Paolo; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  IV paracetamol effect on propofol-ketamine consumption in paediatric patients undergoing ESWL.

Authors:  H Evren Eker; Oya Yalçin Cok; Pınar Ergenoğlu; Anış Ariboğan; Gülnaz Arslan
Journal:  J Anesth       Date:  2012-02-17       Impact factor: 2.078

3.  The effect of intravenous paracetamol on postoperative pain after lumbar discectomy.

Authors:  Mohammad Shimia; Masoud Parish; Naghi Abedini
Journal:  Asian Spine J       Date:  2014-08-19

Review 4.  Treating common ear problems in pregnancy: what is safe?

Authors:  Petros V Vlastarakos; Thomas P Nikolopoulos; Leonidas Manolopoulos; Eleftherios Ferekidis; George Kreatsas
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-23       Impact factor: 2.503

Review 5.  Treating common problems of the nose and throat in pregnancy: what is safe?

Authors:  Petros V Vlastarakos; Leonidas Manolopoulos; Eleftherios Ferekidis; Aris Antsaklis; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-12       Impact factor: 2.503

6.  Management of acute and post-operative pain in chronic kidney disease.

Authors:  Malvinder S Parmar; Kamalpreet S Parmar
Journal:  F1000Res       Date:  2013-01-30

7.  Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management.

Authors:  Maurizio de Martino; Alberto Chiarugi
Journal:  Pain Ther       Date:  2015-10-30

8.  Identification of the cerebral effects of paracetamol in healthy subjects: an fMRI study.

Authors:  Olivier De Coster; Patrice Forget; Johan De Mey; Peter Van Schuerbeek; Jan Poelaert
Journal:  Br J Pain       Date:  2019-06-04

9.  The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model.

Authors:  Rotem Ben-Shachar; Yifei Chen; Shishi Luo; Catherine Hartman; Michael Reed; H Frederik Nijhout
Journal:  Theor Biol Med Model       Date:  2012-12-19       Impact factor: 2.432

10.  Comparison of analgesic efficacy of intravenous Paracetamol and intravenous dexketoprofen trometamol in multimodal analgesia after hysterectomy.

Authors:  Ciğdem Unal; Türkay Cakan; Bülent Baltaci; Hülya Başar
Journal:  J Res Med Sci       Date:  2013-10       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.